Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-13
2007-11-13
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S649000, C564S163000, C548S545000
Reexamination Certificate
active
11016619
ABSTRACT:
Compounds of methamphetamine derivatives having a meta-substituted alkyl linker on the benzene ring and a protective group on the nitrogen of the methamphetamine hapten. Such compounds have the structurewherein R1is an alkyl linker comprising 2-15 carbon atoms and 0-6 heteroatoms, R2is a leaving group, and R3is a protecting group.
REFERENCES:
patent: 4041076 (1977-08-01), Avenia et al.
patent: 5135863 (1992-08-01), Hu et al.
patent: 5328828 (1994-07-01), Hu et al.
patent: 5501987 (1996-03-01), Ordonez et al.
patent: 2001/0051158 (2001-12-01), Owens et al.
patent: 2003/0119083 (2003-06-01), Owens et al.
patent: 2003/0170917 (2003-09-01), Hui et al.
patent: 2004/0077021 (2004-04-01), Hui et al.
patent: 0375422 (1990-06-01), None
patent: WO 01/81424 (2001-11-01), None
Hui Raymond A.
Vitone Stephen S.
Amick Marilyn L.
Coppins Janet L
McKane Joseph K.
Roche Diagnostics Operatins, Inc.
Roche Diagnostics Operations Inc.
LandOfFree
Methamphetamine derivatives and conjugates for immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methamphetamine derivatives and conjugates for immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methamphetamine derivatives and conjugates for immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877508